#clinicaldevelopment search results

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you! Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too! fiosgenomics.com/reducing-the-d… #clinicaldevelopment #bioinformatics

fiosgenomics's tweet image. Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
fiosgenomics.com/reducing-the-d…
#clinicaldevelopment #bioinformatics

Catalent is proud to attend #CHINATRIALS17! Join us at Booth #6 to meet our team and explore how Catalent’s global expertise and local capabilities can help advance your clinical programs. Book a meeting with us: ow.ly/joIk50Xq0Y6 #ClinicalDevelopment #Biotech #Pharma


Acumen's SVP of Clinical Development, Laura Rosen, MD, PhD, joined an expert panel at the Fluid & Imaging Biomarkers in Neuroscience Summit in Boston to discuss the promise of pTau217 in Alzheimer's Research. #AlzheimersResearch #Biomarkers #ClinicalDevelopment

AcumenPharm's tweet image. Acumen's SVP of Clinical Development, Laura Rosen, MD, PhD, joined an expert panel at the Fluid & Imaging Biomarkers in Neuroscience Summit in Boston to discuss the promise of pTau217 in Alzheimer's Research.

#AlzheimersResearch #Biomarkers #ClinicalDevelopment

Meet Our Medics! Discover how they can support you in achieving an approved CTA or IND status for your medicinal product. Book an exploratory call today scendea.com/contact - #clinicaldevelopment #drugdevelopment #meetourmedics #regulatoryapproval

scendea's tweet image. Meet Our Medics! Discover how they can support you in achieving an approved CTA or IND status for your medicinal product. Book an exploratory call today scendea.com/contact
-
#clinicaldevelopment #drugdevelopment #meetourmedics #regulatoryapproval
scendea's tweet image. Meet Our Medics! Discover how they can support you in achieving an approved CTA or IND status for your medicinal product. Book an exploratory call today scendea.com/contact
-
#clinicaldevelopment #drugdevelopment #meetourmedics #regulatoryapproval
scendea's tweet image. Meet Our Medics! Discover how they can support you in achieving an approved CTA or IND status for your medicinal product. Book an exploratory call today scendea.com/contact
-
#clinicaldevelopment #drugdevelopment #meetourmedics #regulatoryapproval
scendea's tweet image. Meet Our Medics! Discover how they can support you in achieving an approved CTA or IND status for your medicinal product. Book an exploratory call today scendea.com/contact
-
#clinicaldevelopment #drugdevelopment #meetourmedics #regulatoryapproval

Fast Track. Breakthrough. Accelerated Approval. PRIME. Join MMS experts on Oct 21 for a practical session on expedited regulatory pathways. 🎯 Learn what works—and what to plan for 💬 Live Q&A included 🔗 vist.ly/4adj2 #RegulatoryStrategy #ClinicalDevelopment

PharmaIgnite's tweet image. Fast Track. Breakthrough. Accelerated Approval. PRIME. 

Join MMS experts on Oct 21 for a practical session on expedited regulatory pathways. 

🎯 Learn what works—and what to plan for 
💬 Live Q&A included 
🔗 vist.ly/4adj2

#RegulatoryStrategy #ClinicalDevelopment

September is World Alzheimer’s Month — a time to honor the millions of people and families living with this disease, and to recognize the urgency of advancing new therapies. At Unlearn, we apply #AI to solve some of the biggest bottlenecks in #clinicaldevelopment. Learn how our…

UnlearnAI's tweet image. September is World Alzheimer’s Month — a time to honor the millions of people and families living with this disease, and to recognize the urgency of advancing new therapies. At Unlearn, we apply #AI to solve some of the biggest bottlenecks in #clinicaldevelopment. 

Learn how our…

Chroma welcomes Jenny Marlowe, PhD, to #TeamChroma as Chief Development Officer. Jenny brings 15+ years of scientific and leadership experience in translational, preclinical development, and preclinical safety. bit.ly/3K82qsR #ClinicalDevelopment #EpigeneticEditing


🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…

UnlearnAI's tweet image. 🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…
UnlearnAI's tweet image. 🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…

Empowering #biostatistics also means empowering communication. 🗣️ In our new blog post, we explain how our AI-driven #clinicaldevelopment solutions empower statisticians with shared reference points across clinical, statistical, and regulatory teams—simplifying communication,…


🚀 #AI doesn’t replace #biostatistics—it amplifies it. In our new blog post, we share how our AI-driven #clinicaldevelopment solutions, including #digitaltwins of patients, empower statisticians with new ways to detect subtle treatment effects, explore responder subgroups, and…


Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation

UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation

We support Sanofi’s Act4Patients program that aims to reduce the time of #ClinicalDevelopment by 1-2 years. Follow us on the way to faster access to medicine for patients: bit.ly/3uDXCqV #LifeSciences #GetTheFutureYouWant


To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 cmb.ac.lk/fim-signed-mou… #AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships

ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships
ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships
ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships

We are excited to announce we are partnering with @sanofi to enhance safety and efficacy in #ClinicalDevelopment. Our Large Quantitative Models (LQMs) empower scientists to causally filter knowledge graphs, automatically extracting new clinical hypotheses and highlighting those…

SandboxAQ's tweet image. We are excited to announce we are partnering with @sanofi to enhance safety and efficacy in #ClinicalDevelopment. 

Our Large Quantitative Models (LQMs) empower scientists to causally filter knowledge graphs, automatically extracting new clinical hypotheses and highlighting those…

Biotech Under Siege Founders face fierce headwinds—strategic resilience is key. Don’t miss this Thought Leader piece by Justin Kozak, EVP at @FounderShield #biotechnology #clinicaldevelopment hubs.li/Q03PlQVv0


We are helping Sanofi drive #ClinicalResearch forward. Follow us on the way to faster access to medicine for patients: bit.ly/3R4BDAI #ClinicalDevelopment #LifeSciences #GetTheFutureYouWant


Unlearn at #DPHARM2024! 🚀 There's still time to connect with our team and discover how the Unlearn Platform™ solves key pain points across #clinicaldevelopment. 📅 Schedule a time here: bit.ly/47bEX4K

UnlearnAI's tweet image. Unlearn at #DPHARM2024! 🚀 There's still time to connect with our team and discover how the Unlearn Platform™ solves key pain points across #clinicaldevelopment. 

📅 Schedule a time here: bit.ly/47bEX4K

Partnering with a CRO at the right time can make all the difference in streamlining drug development, mitigating risks, and accelerating commercialization. See which time points align best to your development plans: bit.ly/3Rh3cHx #PremierResearch #ClinicalDevelopment


We are working with Sanofi to accelerate #ClinicalDevelopment. We are designing next-gen #ClinicalTrials. Follow us as we are accelerating medical treatment development for patients: bit.ly/411YYHW #LifeSciences #GetTheFutureYouWant


As we continue to progress towards late-stage #ClinicalDevelopment, NMD Pharma is looking for a Clinical Director to join our Medical Science team, based in Aarhus (preferred), Copenhagen, or remote. In this role, you will shape our clinical development strategy, ensure…

NMDPharma's tweet image. As we continue to progress towards late-stage #ClinicalDevelopment, NMD Pharma is looking for a Clinical Director to join our Medical Science team, based in Aarhus (preferred), Copenhagen, or remote. In this role, you will shape our clinical development strategy, ensure…

📊 Finalizing 2026 budgets? You're not just spending, you're making strategic bets to de-risk your program. A quality data foundation pays the highest dividends. See how our services de-risk your trial: valos.it/services/ #ClinicalDevelopment #BiotechStrategy #RiskManagement

valos_it's tweet image. 📊 Finalizing 2026 budgets? You're not just spending, you're making strategic bets to de-risk your program. A quality data foundation pays the highest dividends.
See how our services de-risk your trial: valos.it/services/
#ClinicalDevelopment #BiotechStrategy #RiskManagement

Looking for ways to reduce your #drugdevelopment timeline? This blog is for you! Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too! fiosgenomics.com/reducing-the-d… #clinicaldevelopment #bioinformatics

fiosgenomics's tweet image. Looking for ways to reduce your #drugdevelopment timeline? This blog is for you!

Or, not know much about the time & costs involved in drug development & want to learn? This blog is for you, too!
fiosgenomics.com/reducing-the-d…
#clinicaldevelopment #bioinformatics

Catalent is proud to attend #CHINATRIALS17! Join us at Booth #6 to meet our team and explore how Catalent’s global expertise and local capabilities can help advance your clinical programs. Book a meeting with us: ow.ly/joIk50Xq0Y6 #ClinicalDevelopment #Biotech #Pharma


Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment …erences.wellcomeconnectingscience.org/event/mitochon…

tisentotx's tweet image. Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment …erences.wellcomeconnectingscience.org/event/mitochon…

🧠 As a clinical dev leader, you know excellence. You shouldn't have to explain the basics. What's the one thing you wish your data partner just understood? Explore services built on that principle: valos.it/services/ #ClinicalDevelopment #Biotech #Leadership


LucidQuest Updates > Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases dlvr.it/TP9nVQ #LucidDiligenceBrief #biopharma #clinicaldevelopment Comment below!

_timos_'s tweet image. LucidQuest Updates > Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases dlvr.it/TP9nVQ #LucidDiligenceBrief #biopharma #clinicaldevelopment Comment below!

No results for "#clinicaldevelopment"

Acumen's SVP of Clinical Development, Laura Rosen, MD, PhD, joined an expert panel at the Fluid & Imaging Biomarkers in Neuroscience Summit in Boston to discuss the promise of pTau217 in Alzheimer's Research. #AlzheimersResearch #Biomarkers #ClinicalDevelopment

AcumenPharm's tweet image. Acumen's SVP of Clinical Development, Laura Rosen, MD, PhD, joined an expert panel at the Fluid & Imaging Biomarkers in Neuroscience Summit in Boston to discuss the promise of pTau217 in Alzheimer's Research.

#AlzheimersResearch #Biomarkers #ClinicalDevelopment

Fast Track. Breakthrough. Accelerated Approval. PRIME. Join MMS experts on Oct 21 for a practical session on expedited regulatory pathways. 🎯 Learn what works—and what to plan for 💬 Live Q&A included 🔗 vist.ly/4adj2 #RegulatoryStrategy #ClinicalDevelopment

PharmaIgnite's tweet image. Fast Track. Breakthrough. Accelerated Approval. PRIME. 

Join MMS experts on Oct 21 for a practical session on expedited regulatory pathways. 

🎯 Learn what works—and what to plan for 
💬 Live Q&A included 
🔗 vist.ly/4adj2

#RegulatoryStrategy #ClinicalDevelopment

Beautiful setting @HylandsEstate & beautiful weather to present at the @NHSHEE_EoE MSE Advanced Practice Conference today. Great to see @EEAST_UrgCare colleagues in attendance & to fly the flag for the work we are doing at the Trust. #AdvancingPractice #ClinicalDevelopment #ACP

antkitchener's tweet image. Beautiful setting @HylandsEstate & beautiful weather to present at the @NHSHEE_EoE MSE Advanced Practice Conference today. Great to see @EEAST_UrgCare colleagues in attendance & to fly the flag for the work we are doing at the Trust. #AdvancingPractice #ClinicalDevelopment #ACP

To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 cmb.ac.lk/fim-signed-mou… #AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships

ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships
ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships
ColomboUni's tweet image. To strengthen academic research in clinical product development with Ayurveda and herbal industry partners, FIM signed seven MOUs with industrial parties.🌿 
cmb.ac.lk/fim-signed-mou…
#AyurvedaResearch #HerbalMedicine #ClinicalDevelopment #MOUs #ResearchPartnerships

Conference season starts in two weeks! Me & Nicolas will be in Brussels for the @ESWInfluenza #RSV Summit. @pfizer RSV vaccine is one of @hVIVO_UK best case studies, demonstrating how CHIM studies speed-up path to patients. Let's meet! #clinicaldevelopment #clinicaltrials #hvo

eglepavyde's tweet image. Conference season starts in two weeks! Me & Nicolas will be in Brussels for the @ESWInfluenza #RSV Summit. @pfizer RSV vaccine is one of @hVIVO_UK best case studies, demonstrating how CHIM studies speed-up path to patients. Let's meet!
#clinicaldevelopment #clinicaltrials #hvo

Do you miss the old days when all you needed to predict the future was 200 industry experts with over 2,500 yours of experience? This was our view of the future at the end of 2022: lnkd.in/emecrjbQ Love to have your feedback. #pcmg #clinicaltrials #clinicaldevelopment

niche_science's tweet image. Do you miss the old days when all you needed to predict the future was 200 industry experts with over 2,500 yours of experience? This was our view of the future at the end of 2022: lnkd.in/emecrjbQ

Love to have your feedback.

#pcmg #clinicaltrials #clinicaldevelopment

Have you explored our open positions yet? We're hiring! Join the innovators setting the pace for #AI in #clinicaldevelopment. 🚀 bit.ly/4njnC1d

UnlearnAI's tweet image. Have you explored our open positions yet? We're hiring! Join the innovators setting the pace for #AI in #clinicaldevelopment. 🚀 bit.ly/4njnC1d

September is World Alzheimer’s Month — a time to honor the millions of people and families living with this disease, and to recognize the urgency of advancing new therapies. At Unlearn, we apply #AI to solve some of the biggest bottlenecks in #clinicaldevelopment. Learn how our…

UnlearnAI's tweet image. September is World Alzheimer’s Month — a time to honor the millions of people and families living with this disease, and to recognize the urgency of advancing new therapies. At Unlearn, we apply #AI to solve some of the biggest bottlenecks in #clinicaldevelopment. 

Learn how our…

Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation

UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation
UnlearnAI's tweet image. Unlearn Team at #AAIC24!🚀 Stop by booth #1145 to learn more about our Unlearn Platform, a new tool leveraging study participants’ #digitaltwins to solve key pain points across #clinicaldevelopment. @alzassociation

We're attending Biomarkers 2024! We can’t wait to join prominent leaders and scientists in sharing new case studies, data, and industry outlook. Hope to see you there! #BiomarkersSeries24 #Biomarkers #ClinicalDevelopment #PrecisionMedicine #DigitalPathology #abcam

abcam's tweet image. We're attending Biomarkers 2024! We can’t wait to join prominent leaders and scientists in sharing new case studies, data, and industry outlook. 

Hope to see you there!

#BiomarkersSeries24 #Biomarkers #ClinicalDevelopment #PrecisionMedicine #DigitalPathology #abcam

“We're excited to progress the #clinicaldevelopment of this therapy to test a truly novel approach, treating severe #viralinfections with live cells to replenish and bolster patients' immune systems," commented Dr. Delaney CSO/CMO. Read: bit.ly/4962Quy $COEP #Science

coeptistx's tweet image. “We're excited to progress the #clinicaldevelopment of this therapy to test a truly novel approach, treating severe #viralinfections with live cells to replenish and bolster patients' immune systems," commented Dr. Delaney CSO/CMO. Read: bit.ly/4962Quy $COEP #Science

Unlearn at #DPHARM2024! 🚀 There's still time to connect with our team and discover how the Unlearn Platform™ solves key pain points across #clinicaldevelopment. 📅 Schedule a time here: bit.ly/47bEX4K

UnlearnAI's tweet image. Unlearn at #DPHARM2024! 🚀 There's still time to connect with our team and discover how the Unlearn Platform™ solves key pain points across #clinicaldevelopment. 

📅 Schedule a time here: bit.ly/47bEX4K

🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…

UnlearnAI's tweet image. 🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…
UnlearnAI's tweet image. 🌐 According to the @WHO, major depressive disorder impacts approximately 280 million people globally, while schizophrenia affects about 24 million. To accelerate #clinicaldevelopment and bring new treatments to patients faster, we launched #digitaltwin generators for both…

🌐 Join this webinar to gain insights on how early-stage pharmaceutical development is crucial for successful trials and regulatory approvals, and why collaboration with CDMOs is vital. 🔗 Register here: buff.ly/46F5K8u #DrugDevelopment #ClinicalDevelopment

Xtalks's tweet image. 🌐 Join this webinar to gain insights on how early-stage pharmaceutical development is crucial for successful trials and regulatory approvals, and why collaboration with CDMOs is vital.

🔗 Register here: buff.ly/46F5K8u 

#DrugDevelopment #ClinicalDevelopment

In the midst of hectic week, great to spend a couple of hours talking to our @EEAST_Education @uocparamedics Paramedic Degree Apprentice programme about a few things 🧠 . #FutureParamedics #ClinicalDevelopment #WeAreEEAST

antkitchener's tweet image. In the midst of hectic week, great to spend a couple of hours talking to our @EEAST_Education @uocparamedics Paramedic Degree Apprentice programme about a few things 🧠 . #FutureParamedics #ClinicalDevelopment #WeAreEEAST

Building an integrated evidence plan is a major milestone for life sciences teams—but execution is critical. These three best practices can help: bit.ly/44qmq5j #Pharma #ClinicalDevelopment #IntegratedEvidence

ZSAssociates's tweet image. Building an integrated evidence plan is a major milestone for life sciences teams—but execution is critical. These three best practices can help: bit.ly/44qmq5j

#Pharma #ClinicalDevelopment #IntegratedEvidence

Quanterix is attending #BiomarkersSeries23! Join us as we connect with notable industry leaders and scientists, sharing new case studies, innovative data, and industry outlook. Will we see you there? bit.ly/3lbFwI4 @bmd_congress #Biomarkers #ClinicalDevelopment

QuanterixSimoa's tweet image. Quanterix is attending #BiomarkersSeries23! Join us as we connect with notable industry leaders and scientists, sharing new case studies, innovative data, and industry outlook. Will we see you there? bit.ly/3lbFwI4 
@bmd_congress #Biomarkers #ClinicalDevelopment

Meet Kevin Vernarec, Sr. VP, Global Head of #LatePhase Clinical Development at #QPS. Kevin has been a significant part of QPS for 7 years, bringing an outstanding 40 years of experience in #clinicaldevelopment. Learn more qps.com/about/ or email [email protected].

QPSHoldingsLLC's tweet image. Meet Kevin Vernarec, Sr. VP, Global Head of #LatePhase Clinical  Development at #QPS. Kevin has been a significant part of QPS for 7 years, bringing an outstanding 40 years of experience in #clinicaldevelopment. Learn more qps.com/about/ or email info@qps.com.

Heading to Montreal for the 35th International Symposium on ALS/MND? 🍁 Connect with us to learn how our AI-generated participants’ #digitaltwins can optimize #clinicaldevelopment, from reducing control arm sizes to boosting power in #ALS studies. Register now:…

UnlearnAI's tweet image. Heading to Montreal for the 35th International Symposium on ALS/MND? 🍁 Connect with us to learn how our AI-generated participants’ #digitaltwins can optimize #clinicaldevelopment, from reducing control arm sizes to boosting power in #ALS studies. Register now:…

Loading...

Something went wrong.


Something went wrong.


United States Trends